The absence of reactive oxygen species production protects mice against bleomycin-induced pulmonary fibrosis

被引:161
|
作者
Manoury, B
Nenan, S
Leclerc, O
Guenon, I
Boichot, E
Planquois, JM
Bertrand, CP
Lagente, V [1 ]
机构
[1] Univ Rennes 1, Lab Pharmacodynamie & Pharmacol Mol, INSERM, U620, Rennes, France
[2] Pfizer Global R&D, Fresnes Labs, Fresnes, France
关键词
D O I
10.1186/1465-9921-6-11
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Reactive oxygen species and tissue remodeling regulators, such as metalloproteinases (MMPs) and their inhibitors (TIMPs), are thought to be involved in the development of pulmonary fibrosis. We investigated these factors in the fibrotic response to bleomycin of p47(phox)-/- (KO) mice, deficient for ROS production through the NADPH-oxidase pathway. Methods: Mice are administered by intranasal instillation of 0.1 mg bleomycin. Either 24 h or 14 days after, mice were anesthetized and underwent either bronchoalveolar lavage (BAL) or lung removal. Results: BAL cells from bleomycin treated WT mice showed enhanced ROS production after PMA stimulation, whereas no change was observed with BAL cells from p47(phox)-/- mice. At day 1, the bleomycin-induced acute inflammatory response (increased neutrophil count and MMP-9 activity in the BAL fluid) was strikingly greater in KO than wild-type (WT) mice, while IL-6 levels increased significantly more in the latter. Hydroxyproline assays in the lung tissue 14 days after bleomycin administration revealed the absence of collagen deposition in the lungs of the KO mice, which had significantly lower hydroxyproline levels than the WT mice. The MMP-9/TIMP-1 ratio did not change at day 1 after bleomycin administration in WT mice, but increased significantly in the KO mice. By day 14, the ratio fell significantly from baseline in both strains, but more in the WT than KO strains. Conclusions: These results suggest that NADPH-oxidase-derived ROS are essential to the development of pulmonary fibrosis. The absence of collagen deposition in KO mice seems to be associated with an elevated MMP-9/TIMP-1 ratio in the lungs. This finding highlights the importance of metalloproteinases and protease/anti-protease imbalances in pulmonary fibrosis.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Protective and therapeutic effect of felodipine against bleomycin-induced pulmonary fibrosis in mice
    Tanaka, Ken-ichiro
    Niino, Tomomi
    Ishihara, Tomoaki
    Takafuji, Ayaka
    Takayama, Takahiro
    Kanda, Yuki
    Sugizaki, Toshifumi
    Tamura, Fumiya
    Kurotsu, Shota
    Kawahara, Masahiro
    Mizushima, Tohru
    SCIENTIFIC REPORTS, 2017, 7
  • [32] Protective and therapeutic effect of felodipine against bleomycin-induced pulmonary fibrosis in mice
    Ken-ichiro Tanaka
    Tomomi Niino
    Tomoaki Ishihara
    Ayaka Takafuji
    Takahiro Takayama
    Yuki Kanda
    Toshifumi Sugizaki
    Fumiya Tamura
    Shota Kurotsu
    Masahiro Kawahara
    Tohru Mizushima
    Scientific Reports, 7
  • [33] Effect of antibody against integrin α4 on bleomycin-induced pulmonary fibrosis in mice
    Wang, QJ
    Wang, YJ
    Hyde, DM
    Gotwals, PJ
    Lobb, RR
    Ryan, ST
    Giri, SN
    BIOCHEMICAL PHARMACOLOGY, 2000, 60 (12) : 1949 - 1958
  • [34] Apigenin protects against bleomycin-induced lung fibrosis in rats
    Chen, Ling
    Zhao, Wei
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 11 (01) : 230 - 234
  • [35] Simvastatin attenuates bleomycin-induced pulmonary fibrosis in mice
    OU Xue-mei
    Department of Respiratory Medicine
    中华医学杂志(英文版), 2008, (18) : 1821 - 1829
  • [36] Vagotomy attenuates bleomycin-induced pulmonary fibrosis in mice
    Song, Nana
    Liu, Jun
    Shaheen, Saad
    Du, Lei
    Proctor, Mary
    Roman, Jesse
    Yu, Jerry
    SCIENTIFIC REPORTS, 2015, 5
  • [37] Epimorphin in bleomycin-induced pulmonary fibrosis its mice
    Terasaki, Y
    CHEST, 2001, 120 (01) : 30S - 32S
  • [38] Danaparoid Attenuates Bleomycin-Induced Pulmonary Fibrosis In Mice
    Wang, X.
    Tanino, Y.
    Nikaido, T.
    Kikuchi, M.
    Sato, Y.
    Fukuhara, N.
    Misa, K.
    Togawa, R.
    Suzuki, Y.
    Uematsu, M.
    Fukuhara, A.
    Sato, S.
    Saito, J.
    Yokouchi, H.
    Munakata, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [39] Imrecoxib attenuates bleomycin-induced pulmonary fibrosis in mice
    Miao, Yang
    Yang, Yue
    Li, Xiaohe
    Meng, Lingxin
    Mao, Jiahe
    Zhang, Jianwei
    Gao, Jingjing
    Yang, Cheng
    Gu, Xiaoting
    Zhou, Honggang
    Zhang, Yanping
    HELIYON, 2023, 9 (11)
  • [40] The role of eCIRP in bleomycin-induced pulmonary fibrosis in mice
    Bolourani, Siavash
    Sari, Ezgi
    Brenner, Max
    Wang, Ping
    PLOS ONE, 2022, 17 (04):